Summary

The global Brain-computer Interface System market size is predicted to grow from US$ 818 million in 2025 to US$ 3009 million in 2032; it is expected to grow at a CAGR of 21.2% from 2026 to 2032.
Brain-computer Interface System refers to an integrated hardware-software system that establishes a direct information pathway between neural activity and computers, assistive devices, rehabilitation equipment, robots, transportation systems or neuromodulation devices. Also referred to as a BCI system or brain-machine interface system, the product normally combines neural-signal electrodes or implantable interfaces, low-noise analog front ends, amplification and digital conversion modules, wired or wireless transmission, real-time preprocessing and neural-decoding software, application management software, and an external control, feedback or stimulation device. The research scope covers non-invasive systems based mainly on EEG, fNIRS or MEG; semi-invasive systems using epidural, cortical-surface or endovascular interfaces; and invasive systems using intracortical penetrating electrodes to capture spikes and local field potentials. Products range from low-channel portable headsets to high-density platforms exceeding 128 channels. Their core functions include neural-state recognition, movement-intention decoding, communication restoration, external-device control, neurofeedback, functional compensation, rehabilitation training and closed-loop neurological treatment. The market focuses on deliverable system-level products with proprietary acquisition hardware, integrated decoding functions and an identifiable interaction or feedback workflow across medical, research, consumer, industrial, transportation and specialized applications.
Key Findings
2025 global deliveries reached approximately 440,000 Brain-computer Interface Systems
Average manufacturer selling price was approximately US$1,900 per delivered system
Non-invasive systems represented the majority of global unit shipments
Medical and research applications concentrated most professional system value
Market Trends
The Brain-computer Interface System market is shifting from competition in standalone EEG amplifiers or wearable headsets toward competition in complete neural-interaction architectures. Customers increasingly assess signal-to-noise ratio, synchronization accuracy, motion-artifact suppression, preparation time, decoding latency, cross-session stability, software openness and compatibility with external equipment rather than relying on channel count alone. Non-invasive products are moving toward dry or semi-dry electrodes, wireless acquisition, compact form factors, real-time APIs and multimodal synchronization with eye tracking, EMG, motion capture, stimulation, virtual reality and robotics. Semi-invasive systems are developing along epidural, cortical-surface and endovascular routes that seek a balance between information quality, surgical complexity and long-term stability. Intracortical platforms continue to pursue higher-density neuronal recording for precise cursor, speech and robotic control, but face more demanding implantation, packaging and calibration requirements. The long-term product direction is an adaptive closed loop in which signal acquisition, decoding, device control and sensory or therapeutic feedback are continuously optimized as one system. Commercial differentiation is consequently migrating toward proprietary neural datasets, application-specific workflows, automated calibration, home-use capability and longitudinal performance rather than basic access to raw brain signals.
Market Dynamics
Drivers
Growth is being driven by converging demand from neuroscience research, neurological rehabilitation, functional compensation, assistive communication and closed-loop treatment. Universities and research institutions require configurable systems for neuro-AI, cognitive neuroscience, multimodal experiments and human-machine interaction, while hospitals need products capable of producing measurable clinical or functional outcomes for patients with spinal-cord injury, stroke, epilepsy and severe communication impairment. Improvements in flexible electrodes, low-noise analog front ends, wireless transmission, embedded computing and machine-learning decoding are making systems more portable and usable outside controlled laboratories. Policy and payment infrastructure are also beginning to move in parallel with technology. China’s brain-computer interface industrial policy identifies electrodes, dedicated chips, complete systems, standards and medical, industrial and consumer applications as priority development areas. The National Healthcare Security Administration has established service-price categories for invasive implantation, device removal and non-invasive fitting, while the NMPA approved an implantable hand-function compensation system in March 2026. These developments reduce uncertainty around clinical workflow and create a more defined transition from research projects to regulated product deployment.
Restraints
The principal restraint is the performance gap between laboratory demonstration and reliable daily use. Non-invasive EEG systems are affected by skull attenuation, electrode-contact variation, muscle and eye artefacts, head movement and environmental noise, making decoding accuracy and repeatability highly dependent on the user, task and operating environment. Additional channels may improve spatial coverage but also increase preparation time, calibration complexity, data-processing requirements and operator dependence. Semi-invasive and invasive systems carry substantially higher development and delivery costs related to biocompatible materials, microfabrication, hermetic packaging, sterile production, neurosurgery, clinical trials and long-term follow-up. Endovascular approaches must manage vascular access, anatomical limitations and antithrombotic requirements, while cortical-surface and intracortical systems face infection, tissue response, electrode migration and signal degradation risks. Medical adoption also depends on physician training, hospital capacity, reimbursement and evidence that benefits persist beyond selected clinical-study participants. These limitations create a highly uneven market in which low-cost systems can scale rapidly by volume, while high-value medical systems require long commercialization cycles and significant post-market support.
Opportunities
The most immediate opportunities lie in converting general-purpose neural acquisition platforms into validated systems for defined workflows. Home and community rehabilitation can combine portable EEG hardware, intention decoding, robotic gloves, functional electrical stimulation or exoskeletons with clinician-facing software and remote model updates. Assistive communication products can extend from cursor control to text generation, environmental control and robotic-device operation for patients with paralysis or amyotrophic lateral sclerosis. Closed-loop neurological treatment offers a separate high-value opportunity in which continuous neural monitoring triggers personalized stimulation, with epilepsy providing the most established commercial model. Consumer and enterprise products may integrate brain sensing into headphones, headbands, VR equipment, safety wearables and driver-monitoring systems, provided that measurable benefits justify continued use. Semi-invasive systems may open a clinically relevant middle path between non-invasive accessibility and intracortical information density. China’s approval of an epidural hand-function compensation system, Precision Neuroscience’s FDA-cleared cortical interface, and advancing endovascular and intracortical clinical programs indicate that multiple interface routes can coexist rather than converge on a single dominant architecture.
Challenges
Long-term market development requires technical reliability, clinical evidence, regulatory compliance and sustainable economics to be achieved simultaneously. Neural signals differ materially across users and drift over time, creating persistent challenges in model transfer, recalibration and performance validation. Implantable systems must maintain signal quality while minimizing heat, power consumption, tissue reaction, wireless-transmission failure and replacement risk. The sector also lacks fully harmonized terminology, performance benchmarks, channel-count definitions, data formats and interoperability standards, complicating product comparison and multi-centre validation. Brain data introduces additional requirements around informed consent, cybersecurity, data ownership, mental privacy and the permitted use of neural information. Commercial risk is equally important. Consumer products may show measurable neural-state signals without delivering sufficient recurring utility, while medical companies can generate high product gross margins but still incur substantial clinical, regulatory, physician-training and sales expenses. Scaling therefore depends not only on decoding accuracy but also on standard surgical procedures, application-specific evidence, reimbursement, service capacity and the ability to support patients over extended periods.
Industry Chain Analysis
The upstream Brain-computer Interface System chain consists of wet, dry and semi-dry scalp electrodes; flexible epidural and cortical electrode arrays; penetrating microelectrodes; endovascular electrode structures; conductive and biocompatible materials; hermetic packaging; low-noise amplifiers; analog front-end chips; ADCs; processors; wireless-communication and power modules; batteries; connectors; surgical tools; stimulation modules; and precision mechanical components. Upstream specifications determine signal amplitude, bandwidth, spatial resolution, channel density, noise, power consumption, thermal safety, comfort, implantation difficulty and long-term stability. Non-invasive products place greater emphasis on electrode consistency, ergonomic wearability, rapid setup and resistance to motion artefacts. Implantable products allocate more value and development expenditure to microfabrication, flexible materials, packaging reliability, sterilization, wireless power and surgical compatibility.
Midstream manufacturers integrate the neural interface, acquisition electronics, signal transmission, real-time decoding, application software and external feedback device into a deliverable system. Value creation is concentrated in reproducible signal acquisition, low-latency processing, automated calibration, cross-session model stability, integration with third-party devices and regulatory or clinical validation. Standardized low-channel hardware faces increasing price competition, shifting profit toward software licenses, development tools, validated application modules, consumables and technical services. Research-grade and medical systems retain stronger pricing power because customers require data quality, synchronization, technical support and workflow continuity. Implantable and closed-loop systems can achieve high product margins, but those margins must fund clinical trials, quality systems, regulatory submissions, surgical training and long-term patient management. Downstream customers include universities, hospitals, rehabilitation centres, neurological clinics, assistive-technology providers, consumer-electronics companies, industrial operators, transportation users and specialized government institutions.
Segment Insights
By interface type, non-invasive systems account for the majority of shipments because they offer lower risk, broader availability and shorter procurement cycles across education, research, consumer interaction and rehabilitation. Semi-invasive systems cover epidural, cortical-surface and endovascular routes that record population-level cortical activity without penetrating neural tissue. These architectures generally offer stronger and more spatially specific signals than scalp EEG while reducing some of the tissue-response risks associated with intracortical arrays. Intracortical systems record spikes and local field potentials and provide the highest potential information density for precise movement, speech and sensory decoding, but their deployment remains constrained by surgical risk, long-term signal stability and high development costs. EEG remains the dominant signal modality by unit volume, while ECoG, spikes and LFPs concentrate high-value clinical and advanced research activity. fNIRS, MEG and multimodal configurations occupy specialized research, cognitive assessment and hybrid-interface niches.
Low-channel 1–8 and 9–32-channel products dominate portable, educational, consumer and rapid-development applications. Systems in the 33–128-channel range serve advanced neuroscience, high-density EEG, brain mapping and complex multimodal experiments, while platforms above 128 channels, including 128–256-channel and higher-density configurations, support detailed cortical recording and advanced implantable research. Price and margin differences between these segments are substantial. Neuracle Technology’s prospectus reported 488 EEG acquisition systems sold in 2025 at an average tax-exclusive price of RMB159,100 per system and a 77.92% gross margin, demonstrating the economics of specialized professional equipment relative to the global weighted average price. Within applications, research and education provide the broadest established customer base, while medical rehabilitation, functional compensation and neurological treatment concentrate higher system value. Daily-life consumption, industrial control and transportation remain earlier-stage markets in which adoption depends on comfort, calibration speed and demonstrable operational benefits.
Downstream Market Opportunities
Downstream demand is becoming more application-specific. Research users require raw-data access, precise event synchronization, configurable channels and compatibility with MATLAB, Python, BCI2000, OpenViBE and multimodal laboratory equipment. Medical customers require repeatable protocols, clinical-grade reliability, therapist or physician interfaces and connectivity with robotic gloves, functional electrical stimulation, wheelchairs, prostheses and neuromodulation equipment. In rehabilitation, the commercial opportunity increasingly combines immediate functional compensation with repeated training intended to promote longer-term recovery. Closed-loop treatment customers place greater emphasis on biomarker detection, stimulation accuracy, longitudinal data and patient-management services. Daily-life and entertainment products require unobtrusive form factors and minimal calibration; industrial and transportation applications require robust state monitoring under motion, vibration and electromagnetic interference. Military and specialized government applications are more likely to focus on training, cognitive-load assessment, fatigue monitoring and complex human-machine interaction. Across these markets, suppliers able to deliver a validated end-to-end workflow rather than a generic signal stream are positioned to capture a larger proportion of downstream value.
Regional Insights
North America remains the principal high-value clinical and venture-backed development region. It contains commercially established closed-loop neurological treatment, intracortical clinical programs, endovascular systems and cortical-surface interfaces. NeuroPace provides a commercial benchmark: its RNS System generated US$81.7 million in 2025 revenue with an 81.9% product gross margin. Neuralink is conducting trials for computer and robotic-arm control, Synchron is evaluating an investigational endovascular system, Precision Neuroscience has obtained FDA clearance for its cortical interface, and Paradromics received authorization to initiate a clinical study of its fully implantable system. The region’s advantages include specialist clinical centres, regulatory experience, medical-device financing and access to software and AI capabilities, although development and patient-support costs remain high.
Europe has a strong position in research-grade EEG, neurorehabilitation, multimodal acquisition and open scientific software ecosystems, supported by companies such as g.tec, Brain Products, ANT Neuro, Bitbrain, Mentalab, mBrainTrain and Neuroelectrics. China is developing a broader manufacturing and application base spanning non-invasive research systems, rehabilitation equipment, consumer products and multiple implantable routes. The NMPA approval of an epidural Brain-computer Interface System, the establishment of medical-service price categories and expanding clinical programs have strengthened China’s position in early medical commercialization. Japan retains capabilities in fNIRS, MEG and clinical neurodiagnostic equipment, while South Korea, Taiwan and Southeast Asia remain more concentrated in research institutions, components, clinical collaboration and application development than in globally scaled system brands. Regional competition is therefore differentiated: North America leads high-value clinical innovation, Europe remains strong in research platforms, and China is accelerating full-chain localization and clinical deployment.
Competitive Landscape Analysis
The Brain-computer Interface System market has a layered competitive structure. In commercial non-invasive research and development platforms, g.tec, Brain Products, ANT Neuro, OpenBCI, Emotiv, NeuroSky, Bitbrain, Neuroelectrics, Mentalab, mBrainTrain, CGX Systems, Wearable Sensing, Compumedics Neuroscan, Neuracle Technology and BrainCo compete through signal quality, channel density, wireless performance, electrode preparation, synchronization, software openness and global research-channel coverage. InteraXon, Neurable, Neurosity and SmartCap emphasize consumer, enterprise or industrial form factors and applied neural-state interaction. In medical rehabilitation, Chinese suppliers such as BrainCo, Neuracle Technology, CUSOFT, Deayea, Entertech, HNNK, Vishee Medical, Xiangyu Medical, Medlander, Longest and other specialist developers compete through hospital access, rehabilitation-device integration and localized clinical service. The implantable and closed-loop segment is technologically fragmented: Neuralink, Paradromics and Blackrock Neurotech pursue intracortical interfaces; Precision Neuroscience focuses on cortical-surface access; Synchron uses an endovascular route; NeuroPace operates an established responsive neurostimulation business; and Neuracle Technology has commercialized an epidural functional-compensation system in China. StairMed, NeuroXess, Enlight Medical, Xinzhida, Zhirun Medical and other Chinese developers are advancing different implantable architectures and clinical pipelines. Competitive advantage increasingly depends on control of the complete stack—electrodes, acquisition chips, wireless transmission, decoding software, clinical data, regulatory evidence, external devices and long-term service. Scale in low-cost hardware alone is unlikely to establish durable leadership, while companies possessing validated workflows and proprietary longitudinal neural data can sustain stronger pricing and higher entry barriers.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Brain-computer Interface System Industry Forecast” looks at past sales and reviews total world Brain-computer Interface System sales in 2025, providing a comprehensive analysis by region and market sector of projected Brain-computer Interface System sales for 2026 through 2032. With Brain-computer Interface System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Brain-computer Interface System industry.
This Insight Report provides a comprehensive analysis of the global Brain-computer Interface System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Brain-computer Interface System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Brain-computer Interface System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Brain-computer Interface System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Brain-computer Interface System.
This report presents a comprehensive overview, market shares, and growth opportunities of Brain-computer Interface System market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Non-Invasive
Partially Invasive
Invasive
Segmentation by Signal Acquisition Channel Count:
1 To 8 Channels
9 To 32 Channels
33 To 128 Channels
128 To 256 Channels
Segmentation by Primary Signal Modality:
EEG
ECoG
Spikes & LFPs
fNIRS, MEG and Others
Segmentation by Application:
Medical Rehabilitation
Daily Life and Entertainment Consumption
Industrial Control
Traffic Driving
Research & Education
Military and Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Neuralink
OpenBCI
NeuroPace
Emotiv
NeuroSky
ANT Neuro
Blackrock Neurotech
Synchron
g.tec medical engineering GmbH
Brain Products
Bitbrain
Precision Neuroscience
Paradromics
InteraXon
Neurable
Mentalab
mBrainTrain
Neuroelectrics
CGX Systems (formerly Cognionics)
Neurosity
Wearable Sensing
Compumedics Neuroscan
SmartCap(Wenco)
Shimadzu
BrainCo
Neuracle Technology
CUSOFT
Deayea
Entertech
HNNK
StairMed
NeuroXess
Enlight Medical
Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd.
Hanix
Zhongdian Yunnao (Tianjin) Technology Co., Ltd.
Beijing Xinzhida Neural Technology Co., Ltd
Nanjing Vishee Medical Technology Co., Ltd.
Xiangyu Medical Co.,Ltd.
Jiangsu Apon Medical Technology Co.,Ltd.
Boling Brain Machine (Hangzhou) Technology Co., Ltd.
Medlander
Shanghai HeartCare Medical Technology Corporation Limited
Beijing Chieftain Control Engineering Technology Co., Ltd.
Kingfar International,Inc.
Suzhou Nianji Intelligent Technology Co., Ltd.
Beijing Zhiran Medical Technology Co., Ltd
Greatthink Medical Technology
Danyang Huichuang Medical Equipment Co., Ltd.
OYMotion
Aura MedTech
Casibrain
Gestala
WE-LINKING
Key Questions Addressed in this Report
What is the 10-year outlook for the global Brain-computer Interface System market?
What factors are driving Brain-computer Interface System market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Brain-computer Interface System market opportunities vary by end market size?
How does Brain-computer Interface System break out by Type, by Application?

ページTOPに戻る

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Brain-computer Interface System Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Brain-computer Interface System by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Brain-computer Interface System by Country/Region, 2021, 2025 & 2032
2.2 Brain-computer Interface System Segment by Type
2.2.1 Non-Invasive
2.2.2 Partially Invasive
2.2.3 Invasive
2.2.4 Brain-computer Interface System Sales by Type
2.2.4.1 Global Brain-computer Interface System Sales Market Share by Type (2021-2026)
2.2.4.2 Global Brain-computer Interface System Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Brain-computer Interface System Sale Price by Type (2021-2026)
2.3 Brain-computer Interface System Segment by Signal Acquisition Channel Count
2.3.1 1 To 8 Channels
2.3.2 9 To 32 Channels
2.3.3 33 To 128 Channels
2.3.4 128 To 256 Channels
2.3.5 Brain-computer Interface System Sales by Signal Acquisition Channel Count
2.3.5.1 Global Brain-computer Interface System Sales Market Share by Signal Acquisition Channel Count (2021-2026)
2.3.5.2 Global Brain-computer Interface System Revenue and Market Share by Signal Acquisition Channel Count (2021-2026)
2.3.5.3 Global Brain-computer Interface System Sale Price by Signal Acquisition Channel Count (2021-2026)
2.4 Brain-computer Interface System Segment by Primary Signal Modality
2.4.1 EEG
2.4.2 ECoG
2.4.3 Spikes & LFPs
2.4.4 fNIRS, MEG and Others
2.4.5 Brain-computer Interface System Sales by Primary Signal Modality
2.4.5.1 Global Brain-computer Interface System Sales Market Share by Primary Signal Modality (2021-2026)
2.4.5.2 Global Brain-computer Interface System Revenue and Market Share by Primary Signal Modality (2021-2026)
2.4.5.3 Global Brain-computer Interface System Sale Price by Primary Signal Modality (2021-2026)
2.5 Brain-computer Interface System Segment by Application
2.5.1 Medical Rehabilitation
2.5.2 Daily Life and Entertainment Consumption
2.5.3 Industrial Control
2.5.4 Traffic Driving
2.5.5 Research & Education
2.5.6 Military and Others
2.5.7 Brain-computer Interface System Sales by Application
2.5.7.1 Global Brain-computer Interface System Sale Market Share by Application (2021-2026)
2.5.7.2 Global Brain-computer Interface System Revenue and Market Share by Application (2021-2026)
2.5.7.3 Global Brain-computer Interface System Sale Price by Application (2021-2026)

3 Global by Company
3.1 Global Brain-computer Interface System Breakdown Data by Company
3.1.1 Global Brain-computer Interface System Annual Sales by Company (2021-2026)
3.1.2 Global Brain-computer Interface System Sales Market Share by Company (2021-2026)
3.2 Global Brain-computer Interface System Annual Revenue by Company (2021-2026)
3.2.1 Global Brain-computer Interface System Revenue by Company (2021-2026)
3.2.2 Global Brain-computer Interface System Revenue Market Share by Company (2021-2026)
3.3 Global Brain-computer Interface System Sale Price by Company
3.4 Key Manufacturers Brain-computer Interface System Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Brain-computer Interface System Product Location Distribution
3.4.2 Players Brain-computer Interface System Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 World Historic Review for Brain-computer Interface System by Geographic Region
4.1 World Historic Brain-computer Interface System Market Size by Geographic Region (2021-2026)
4.1.1 Global Brain-computer Interface System Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Brain-computer Interface System Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Brain-computer Interface System Market Size by Country/Region (2021-2026)
4.2.1 Global Brain-computer Interface System Annual Sales by Country/Region (2021-2026)
4.2.2 Global Brain-computer Interface System Annual Revenue by Country/Region (2021-2026)
4.3 Americas Brain-computer Interface System Sales Growth
4.4 APAC Brain-computer Interface System Sales Growth
4.5 Europe Brain-computer Interface System Sales Growth
4.6 Middle East & Africa Brain-computer Interface System Sales Growth

5 Americas
5.1 Americas Brain-computer Interface System Sales by Country
5.1.1 Americas Brain-computer Interface System Sales by Country (2021-2026)
5.1.2 Americas Brain-computer Interface System Revenue by Country (2021-2026)
5.2 Americas Brain-computer Interface System Sales by Type (2021-2026)
5.3 Americas Brain-computer Interface System Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Brain-computer Interface System Sales by Region
6.1.1 APAC Brain-computer Interface System Sales by Region (2021-2026)
6.1.2 APAC Brain-computer Interface System Revenue by Region (2021-2026)
6.2 APAC Brain-computer Interface System Sales by Type (2021-2026)
6.3 APAC Brain-computer Interface System Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 Europe
7.1 Europe Brain-computer Interface System by Country
7.1.1 Europe Brain-computer Interface System Sales by Country (2021-2026)
7.1.2 Europe Brain-computer Interface System Revenue by Country (2021-2026)
7.2 Europe Brain-computer Interface System Sales by Type (2021-2026)
7.3 Europe Brain-computer Interface System Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Brain-computer Interface System by Country
8.1.1 Middle East & Africa Brain-computer Interface System Sales by Country (2021-2026)
8.1.2 Middle East & Africa Brain-computer Interface System Revenue by Country (2021-2026)
8.2 Middle East & Africa Brain-computer Interface System Sales by Type (2021-2026)
8.3 Middle East & Africa Brain-computer Interface System Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Brain-computer Interface System
10.3 Manufacturing Process Analysis of Brain-computer Interface System
10.4 Industry Chain Structure of Brain-computer Interface System

11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Brain-computer Interface System Distributors
11.3 Brain-computer Interface System Customer

12 World Forecast Review for Brain-computer Interface System by Geographic Region
12.1 Global Brain-computer Interface System Market Size Forecast by Region
12.1.1 Global Brain-computer Interface System Forecast by Region (2027-2032)
12.1.2 Global Brain-computer Interface System Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Brain-computer Interface System Forecast by Type (2027-2032)
12.7 Global Brain-computer Interface System Forecast by Application (2027-2032)

13 Key Players Analysis
13.1 Neuralink
13.1.1 Neuralink Company Information
13.1.2 Neuralink Brain-computer Interface System Product Portfolios and Specifications
13.1.3 Neuralink Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Neuralink Main Business Overview
13.1.5 Neuralink Latest Developments
13.2 OpenBCI
13.2.1 OpenBCI Company Information
13.2.2 OpenBCI Brain-computer Interface System Product Portfolios and Specifications
13.2.3 OpenBCI Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 OpenBCI Main Business Overview
13.2.5 OpenBCI Latest Developments
13.3 NeuroPace
13.3.1 NeuroPace Company Information
13.3.2 NeuroPace Brain-computer Interface System Product Portfolios and Specifications
13.3.3 NeuroPace Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 NeuroPace Main Business Overview
13.3.5 NeuroPace Latest Developments
13.4 Emotiv
13.4.1 Emotiv Company Information
13.4.2 Emotiv Brain-computer Interface System Product Portfolios and Specifications
13.4.3 Emotiv Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Emotiv Main Business Overview
13.4.5 Emotiv Latest Developments
13.5 NeuroSky
13.5.1 NeuroSky Company Information
13.5.2 NeuroSky Brain-computer Interface System Product Portfolios and Specifications
13.5.3 NeuroSky Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 NeuroSky Main Business Overview
13.5.5 NeuroSky Latest Developments
13.6 ANT Neuro
13.6.1 ANT Neuro Company Information
13.6.2 ANT Neuro Brain-computer Interface System Product Portfolios and Specifications
13.6.3 ANT Neuro Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 ANT Neuro Main Business Overview
13.6.5 ANT Neuro Latest Developments
13.7 Blackrock Neurotech
13.7.1 Blackrock Neurotech Company Information
13.7.2 Blackrock Neurotech Brain-computer Interface System Product Portfolios and Specifications
13.7.3 Blackrock Neurotech Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Blackrock Neurotech Main Business Overview
13.7.5 Blackrock Neurotech Latest Developments
13.8 Synchron
13.8.1 Synchron Company Information
13.8.2 Synchron Brain-computer Interface System Product Portfolios and Specifications
13.8.3 Synchron Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Synchron Main Business Overview
13.8.5 Synchron Latest Developments
13.9 g.tec medical engineering GmbH
13.9.1 g.tec medical engineering GmbH Company Information
13.9.2 g.tec medical engineering GmbH Brain-computer Interface System Product Portfolios and Specifications
13.9.3 g.tec medical engineering GmbH Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 g.tec medical engineering GmbH Main Business Overview
13.9.5 g.tec medical engineering GmbH Latest Developments
13.10 Brain Products
13.10.1 Brain Products Company Information
13.10.2 Brain Products Brain-computer Interface System Product Portfolios and Specifications
13.10.3 Brain Products Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Brain Products Main Business Overview
13.10.5 Brain Products Latest Developments
13.11 Bitbrain
13.11.1 Bitbrain Company Information
13.11.2 Bitbrain Brain-computer Interface System Product Portfolios and Specifications
13.11.3 Bitbrain Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Bitbrain Main Business Overview
13.11.5 Bitbrain Latest Developments
13.12 Precision Neuroscience
13.12.1 Precision Neuroscience Company Information
13.12.2 Precision Neuroscience Brain-computer Interface System Product Portfolios and Specifications
13.12.3 Precision Neuroscience Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Precision Neuroscience Main Business Overview
13.12.5 Precision Neuroscience Latest Developments
13.13 Paradromics
13.13.1 Paradromics Company Information
13.13.2 Paradromics Brain-computer Interface System Product Portfolios and Specifications
13.13.3 Paradromics Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Paradromics Main Business Overview
13.13.5 Paradromics Latest Developments
13.14 InteraXon
13.14.1 InteraXon Company Information
13.14.2 InteraXon Brain-computer Interface System Product Portfolios and Specifications
13.14.3 InteraXon Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 InteraXon Main Business Overview
13.14.5 InteraXon Latest Developments
13.15 Neurable
13.15.1 Neurable Company Information
13.15.2 Neurable Brain-computer Interface System Product Portfolios and Specifications
13.15.3 Neurable Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Neurable Main Business Overview
13.15.5 Neurable Latest Developments
13.16 Mentalab
13.16.1 Mentalab Company Information
13.16.2 Mentalab Brain-computer Interface System Product Portfolios and Specifications
13.16.3 Mentalab Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Mentalab Main Business Overview
13.16.5 Mentalab Latest Developments
13.17 mBrainTrain
13.17.1 mBrainTrain Company Information
13.17.2 mBrainTrain Brain-computer Interface System Product Portfolios and Specifications
13.17.3 mBrainTrain Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 mBrainTrain Main Business Overview
13.17.5 mBrainTrain Latest Developments
13.18 Neuroelectrics
13.18.1 Neuroelectrics Company Information
13.18.2 Neuroelectrics Brain-computer Interface System Product Portfolios and Specifications
13.18.3 Neuroelectrics Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Neuroelectrics Main Business Overview
13.18.5 Neuroelectrics Latest Developments
13.19 CGX Systems (formerly Cognionics)
13.19.1 CGX Systems (formerly Cognionics) Company Information
13.19.2 CGX Systems (formerly Cognionics) Brain-computer Interface System Product Portfolios and Specifications
13.19.3 CGX Systems (formerly Cognionics) Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 CGX Systems (formerly Cognionics) Main Business Overview
13.19.5 CGX Systems (formerly Cognionics) Latest Developments
13.20 Neurosity
13.20.1 Neurosity Company Information
13.20.2 Neurosity Brain-computer Interface System Product Portfolios and Specifications
13.20.3 Neurosity Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Neurosity Main Business Overview
13.20.5 Neurosity Latest Developments
13.21 Wearable Sensing
13.21.1 Wearable Sensing Company Information
13.21.2 Wearable Sensing Brain-computer Interface System Product Portfolios and Specifications
13.21.3 Wearable Sensing Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 Wearable Sensing Main Business Overview
13.21.5 Wearable Sensing Latest Developments
13.22 Compumedics Neuroscan
13.22.1 Compumedics Neuroscan Company Information
13.22.2 Compumedics Neuroscan Brain-computer Interface System Product Portfolios and Specifications
13.22.3 Compumedics Neuroscan Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021-2026)
13.22.4 Compumedics Neuroscan Main Business Overview
13.22.5 Compumedics Neuroscan Latest Developments
13.23 SmartCap(Wenco)
13.23.1 SmartCap(Wenco) Company Information
13.23.2 SmartCap(Wenco) Brain-computer Interface System Product Portfolios and Specifications
13.23.3 SmartCap(Wenco) Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021-2026)
13.23.4 SmartCap(Wenco) Main Business Overview
13.23.5 SmartCap(Wenco) Latest Developments
13.24 Shimadzu
13.24.1 Shimadzu Company Information
13.24.2 Shimadzu Brain-computer Interface System Product Portfolios and Specifications
13.24.3 Shimadzu Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021-2026)
13.24.4 Shimadzu Main Business Overview
13.24.5 Shimadzu Latest Developments
13.25 BrainCo
13.25.1 BrainCo Company Information
13.25.2 BrainCo Brain-computer Interface System Product Portfolios and Specifications
13.25.3 BrainCo Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021-2026)
13.25.4 BrainCo Main Business Overview
13.25.5 BrainCo Latest Developments
13.26 Neuracle Technology
13.26.1 Neuracle Technology Company Information
13.26.2 Neuracle Technology Brain-computer Interface System Product Portfolios and Specifications
13.26.3 Neuracle Technology Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021-2026)
13.26.4 Neuracle Technology Main Business Overview
13.26.5 Neuracle Technology Latest Developments
13.27 CUSOFT
13.27.1 CUSOFT Company Information
13.27.2 CUSOFT Brain-computer Interface System Product Portfolios and Specifications
13.27.3 CUSOFT Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021-2026)
13.27.4 CUSOFT Main Business Overview
13.27.5 CUSOFT Latest Developments
13.28 Deayea
13.28.1 Deayea Company Information
13.28.2 Deayea Brain-computer Interface System Product Portfolios and Specifications
13.28.3 Deayea Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021-2026)
13.28.4 Deayea Main Business Overview
13.28.5 Deayea Latest Developments
13.29 Entertech
13.29.1 Entertech Company Information
13.29.2 Entertech Brain-computer Interface System Product Portfolios and Specifications
13.29.3 Entertech Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021-2026)
13.29.4 Entertech Main Business Overview
13.29.5 Entertech Latest Developments
13.30 HNNK
13.30.1 HNNK Company Information
13.30.2 HNNK Brain-computer Interface System Product Portfolios and Specifications
13.30.3 HNNK Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021-2026)
13.30.4 HNNK Main Business Overview
13.30.5 HNNK Latest Developments
13.31 StairMed
13.31.1 StairMed Company Information
13.31.2 StairMed Brain-computer Interface System Product Portfolios and Specifications
13.31.3 StairMed Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021-2026)
13.31.4 StairMed Main Business Overview
13.31.5 StairMed Latest Developments
13.32 NeuroXess
13.32.1 NeuroXess Company Information
13.32.2 NeuroXess Brain-computer Interface System Product Portfolios and Specifications
13.32.3 NeuroXess Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021-2026)
13.32.4 NeuroXess Main Business Overview
13.32.5 NeuroXess Latest Developments
13.33 Enlight Medical
13.33.1 Enlight Medical Company Information
13.33.2 Enlight Medical Brain-computer Interface System Product Portfolios and Specifications
13.33.3 Enlight Medical Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021-2026)
13.33.4 Enlight Medical Main Business Overview
13.33.5 Enlight Medical Latest Developments
13.34 Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd.
13.34.1 Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Company Information
13.34.2 Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Brain-computer Interface System Product Portfolios and Specifications
13.34.3 Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021-2026)
13.34.4 Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Main Business Overview
13.34.5 Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Latest Developments
13.35 Hanix
13.35.1 Hanix Company Information
13.35.2 Hanix Brain-computer Interface System Product Portfolios and Specifications
13.35.3 Hanix Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021-2026)
13.35.4 Hanix Main Business Overview
13.35.5 Hanix Latest Developments
13.36 Zhongdian Yunnao (Tianjin) Technology Co., Ltd.
13.36.1 Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Company Information
13.36.2 Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Brain-computer Interface System Product Portfolios and Specifications
13.36.3 Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021-2026)
13.36.4 Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Main Business Overview
13.36.5 Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Latest Developments
13.37 Beijing Xinzhida Neural Technology Co., Ltd
13.37.1 Beijing Xinzhida Neural Technology Co., Ltd Company Information
13.37.2 Beijing Xinzhida Neural Technology Co., Ltd Brain-computer Interface System Product Portfolios and Specifications
13.37.3 Beijing Xinzhida Neural Technology Co., Ltd Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021-2026)
13.37.4 Beijing Xinzhida Neural Technology Co., Ltd Main Business Overview
13.37.5 Beijing Xinzhida Neural Technology Co., Ltd Latest Developments
13.38 Nanjing Vishee Medical Technology Co., Ltd.
13.38.1 Nanjing Vishee Medical Technology Co., Ltd. Company Information
13.38.2 Nanjing Vishee Medical Technology Co., Ltd. Brain-computer Interface System Product Portfolios and Specifications
13.38.3 Nanjing Vishee Medical Technology Co., Ltd. Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021-2026)
13.38.4 Nanjing Vishee Medical Technology Co., Ltd. Main Business Overview
13.38.5 Nanjing Vishee Medical Technology Co., Ltd. Latest Developments
13.39 Xiangyu Medical Co.,Ltd.
13.39.1 Xiangyu Medical Co.,Ltd. Company Information
13.39.2 Xiangyu Medical Co.,Ltd. Brain-computer Interface System Product Portfolios and Specifications
13.39.3 Xiangyu Medical Co.,Ltd. Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021-2026)
13.39.4 Xiangyu Medical Co.,Ltd. Main Business Overview
13.39.5 Xiangyu Medical Co.,Ltd. Latest Developments
13.40 Jiangsu Apon Medical Technology Co.,Ltd.
13.40.1 Jiangsu Apon Medical Technology Co.,Ltd. Company Information
13.40.2 Jiangsu Apon Medical Technology Co.,Ltd. Brain-computer Interface System Product Portfolios and Specifications
13.40.3 Jiangsu Apon Medical Technology Co.,Ltd. Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021-2026)
13.40.4 Jiangsu Apon Medical Technology Co.,Ltd. Main Business Overview
13.40.5 Jiangsu Apon Medical Technology Co.,Ltd. Latest Developments
13.41 Boling Brain Machine (Hangzhou) Technology Co., Ltd.
13.41.1 Boling Brain Machine (Hangzhou) Technology Co., Ltd. Company Information
13.41.2 Boling Brain Machine (Hangzhou) Technology Co., Ltd. Brain-computer Interface System Product Portfolios and Specifications
13.41.3 Boling Brain Machine (Hangzhou) Technology Co., Ltd. Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021-2026)
13.41.4 Boling Brain Machine (Hangzhou) Technology Co., Ltd. Main Business Overview
13.41.5 Boling Brain Machine (Hangzhou) Technology Co., Ltd. Latest Developments
13.42 Medlander
13.42.1 Medlander Company Information
13.42.2 Medlander Brain-computer Interface System Product Portfolios and Specifications
13.42.3 Medlander Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021-2026)
13.42.4 Medlander Main Business Overview
13.42.5 Medlander Latest Developments
13.43 Shanghai HeartCare Medical Technology Corporation Limited
13.43.1 Shanghai HeartCare Medical Technology Corporation Limited Company Information
13.43.2 Shanghai HeartCare Medical Technology Corporation Limited Brain-computer Interface System Product Portfolios and Specifications
13.43.3 Shanghai HeartCare Medical Technology Corporation Limited Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021-2026)
13.43.4 Shanghai HeartCare Medical Technology Corporation Limited Main Business Overview
13.43.5 Shanghai HeartCare Medical Technology Corporation Limited Latest Developments
13.44 Beijing Chieftain Control Engineering Technology Co., Ltd.
13.44.1 Beijing Chieftain Control Engineering Technology Co., Ltd. Company Information
13.44.2 Beijing Chieftain Control Engineering Technology Co., Ltd. Brain-computer Interface System Product Portfolios and Specifications
13.44.3 Beijing Chieftain Control Engineering Technology Co., Ltd. Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021-2026)
13.44.4 Beijing Chieftain Control Engineering Technology Co., Ltd. Main Business Overview
13.44.5 Beijing Chieftain Control Engineering Technology Co., Ltd. Latest Developments
13.45 Kingfar International,Inc.
13.45.1 Kingfar International,Inc. Company Information
13.45.2 Kingfar International,Inc. Brain-computer Interface System Product Portfolios and Specifications
13.45.3 Kingfar International,Inc. Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021-2026)
13.45.4 Kingfar International,Inc. Main Business Overview
13.45.5 Kingfar International,Inc. Latest Developments

14 Research Findings and Conclusion

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Brain-computer Interface System Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Brain-computer Interface System Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Non-Invasive
Table 4. Major Players of Partially Invasive
Table 5. Major Players of Invasive
Table 6. Global Brain-computer Interface System Sales by Type (2021-2026) & (K Units)
Table 7. Global Brain-computer Interface System Sales Market Share by Type (2021-2026)
Table 8. Global Brain-computer Interface System Revenue by Type (2021-2026) & ($ million)
Table 9. Global Brain-computer Interface System Revenue Market Share by Type (2021-2026)
Table 10. Global Brain-computer Interface System Sale Price by Type (2021-2026) & (K US$/Unit)
Table 11. Major Players of 1 To 8 Channels
Table 12. Major Players of 9 To 32 Channels
Table 13. Major Players of 33 To 128 Channels
Table 14. Major Players of 128 To 256 Channels
Table 15. Global Brain-computer Interface System Sales by Signal Acquisition Channel Count (2021-2026) & (K Units)
Table 16. Global Brain-computer Interface System Sales Market Share by Signal Acquisition Channel Count (2021-2026)
Table 17. Global Brain-computer Interface System Revenue by Signal Acquisition Channel Count (2021-2026) & ($ million)
Table 18. Global Brain-computer Interface System Revenue Market Share by Signal Acquisition Channel Count (2021-2026)
Table 19. Global Brain-computer Interface System Sale Price by Signal Acquisition Channel Count (2021-2026) & (K US$/Unit)
Table 20. Major Players of EEG
Table 21. Major Players of ECoG
Table 22. Major Players of Spikes & LFPs
Table 23. Major Players of fNIRS, MEG and Others
Table 24. Global Brain-computer Interface System Sales by Primary Signal Modality (2021-2026) & (K Units)
Table 25. Global Brain-computer Interface System Sales Market Share by Primary Signal Modality (2021-2026)
Table 26. Global Brain-computer Interface System Revenue by Primary Signal Modality (2021-2026) & ($ million)
Table 27. Global Brain-computer Interface System Revenue Market Share by Primary Signal Modality (2021-2026)
Table 28. Global Brain-computer Interface System Sale Price by Primary Signal Modality (2021-2026) & (K US$/Unit)
Table 29. Global Brain-computer Interface System Sale by Application (2021-2026) & (K Units)
Table 30. Global Brain-computer Interface System Sale Market Share by Application (2021-2026)
Table 31. Global Brain-computer Interface System Revenue by Application (2021-2026) & ($ million)
Table 32. Global Brain-computer Interface System Revenue Market Share by Application (2021-2026)
Table 33. Global Brain-computer Interface System Sale Price by Application (2021-2026) & (K US$/Unit)
Table 34. Global Brain-computer Interface System Sales by Company (2021-2026) & (K Units)
Table 35. Global Brain-computer Interface System Sales Market Share by Company (2021-2026)
Table 36. Global Brain-computer Interface System Revenue by Company (2021-2026) & ($ millions)
Table 37. Global Brain-computer Interface System Revenue Market Share by Company (2021-2026)
Table 38. Global Brain-computer Interface System Sale Price by Company (2021-2026) & (K US$/Unit)
Table 39. Key Manufacturers Brain-computer Interface System Producing Area Distribution and Sales Area
Table 40. Players Brain-computer Interface System Products Offered
Table 41. Brain-computer Interface System Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 42. New Products and Potential Entrants
Table 43. Market M&A Activity & Strategy
Table 44. Global Brain-computer Interface System Sales by Geographic Region (2021-2026) & (K Units)
Table 45. Global Brain-computer Interface System Sales Market Share Geographic Region (2021-2026)
Table 46. Global Brain-computer Interface System Revenue by Geographic Region (2021-2026) & ($ millions)
Table 47. Global Brain-computer Interface System Revenue Market Share by Geographic Region (2021-2026)
Table 48. Global Brain-computer Interface System Sales by Country/Region (2021-2026) & (K Units)
Table 49. Global Brain-computer Interface System Sales Market Share by Country/Region (2021-2026)
Table 50. Global Brain-computer Interface System Revenue by Country/Region (2021-2026) & ($ millions)
Table 51. Global Brain-computer Interface System Revenue Market Share by Country/Region (2021-2026)
Table 52. Americas Brain-computer Interface System Sales by Country (2021-2026) & (K Units)
Table 53. Americas Brain-computer Interface System Sales Market Share by Country (2021-2026)
Table 54. Americas Brain-computer Interface System Revenue by Country (2021-2026) & ($ millions)
Table 55. Americas Brain-computer Interface System Sales by Type (2021-2026) & (K Units)
Table 56. Americas Brain-computer Interface System Sales by Application (2021-2026) & (K Units)
Table 57. APAC Brain-computer Interface System Sales by Region (2021-2026) & (K Units)
Table 58. APAC Brain-computer Interface System Sales Market Share by Region (2021-2026)
Table 59. APAC Brain-computer Interface System Revenue by Region (2021-2026) & ($ millions)
Table 60. APAC Brain-computer Interface System Sales by Type (2021-2026) & (K Units)
Table 61. APAC Brain-computer Interface System Sales by Application (2021-2026) & (K Units)
Table 62. Europe Brain-computer Interface System Sales by Country (2021-2026) & (K Units)
Table 63. Europe Brain-computer Interface System Revenue by Country (2021-2026) & ($ millions)
Table 64. Europe Brain-computer Interface System Sales by Type (2021-2026) & (K Units)
Table 65. Europe Brain-computer Interface System Sales by Application (2021-2026) & (K Units)
Table 66. Middle East & Africa Brain-computer Interface System Sales by Country (2021-2026) & (K Units)
Table 67. Middle East & Africa Brain-computer Interface System Revenue Market Share by Country (2021-2026)
Table 68. Middle East & Africa Brain-computer Interface System Sales by Type (2021-2026) & (K Units)
Table 69. Middle East & Africa Brain-computer Interface System Sales by Application (2021-2026) & (K Units)
Table 70. Key Market Drivers & Growth Opportunities of Brain-computer Interface System
Table 71. Key Market Challenges & Risks of Brain-computer Interface System
Table 72. Key Industry Trends of Brain-computer Interface System
Table 73. Brain-computer Interface System Raw Material
Table 74. Key Suppliers of Raw Materials
Table 75. Brain-computer Interface System Distributors List
Table 76. Brain-computer Interface System Customer List
Table 77. Global Brain-computer Interface System Sales Forecast by Region (2027-2032) & (K Units)
Table 78. Global Brain-computer Interface System Revenue Forecast by Region (2027-2032) & ($ millions)
Table 79. Americas Brain-computer Interface System Sales Forecast by Country (2027-2032) & (K Units)
Table 80. Americas Brain-computer Interface System Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 81. APAC Brain-computer Interface System Sales Forecast by Region (2027-2032) & (K Units)
Table 82. APAC Brain-computer Interface System Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 83. Europe Brain-computer Interface System Sales Forecast by Country (2027-2032) & (K Units)
Table 84. Europe Brain-computer Interface System Revenue Forecast by Country (2027-2032) & ($ millions)
Table 85. Middle East & Africa Brain-computer Interface System Sales Forecast by Country (2027-2032) & (K Units)
Table 86. Middle East & Africa Brain-computer Interface System Revenue Forecast by Country (2027-2032) & ($ millions)
Table 87. Global Brain-computer Interface System Sales Forecast by Type (2027-2032) & (K Units)
Table 88. Global Brain-computer Interface System Revenue Forecast by Type (2027-2032) & ($ millions)
Table 89. Global Brain-computer Interface System Sales Forecast by Application (2027-2032) & (K Units)
Table 90. Global Brain-computer Interface System Revenue Forecast by Application (2027-2032) & ($ millions)
Table 91. Neuralink Basic Information, Brain-computer Interface System Manufacturing Base, Sales Area and Its Competitors
Table 92. Neuralink Brain-computer Interface System Product Portfolios and Specifications
Table 93. Neuralink Brain-computer Interface System Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 94. Neuralink Main Business
Table 95. Neuralink Latest Developments
Table 96. OpenBCI Basic Information, Brain-computer Interface System Manufacturing Base, Sales Area and Its Competitors
Table 97. OpenBCI Brain-computer Interface System Product Portfolios and Specifications
Table 98. OpenBCI Brain-computer Interface System Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 99. OpenBCI Main Business
Table 100. OpenBCI Latest Developments
Table 101. NeuroPace Basic Information, Brain-computer Interface System Manufacturing Base, Sales Area and Its Competitors
Table 102. NeuroPace Brain-computer Interface System Product Portfolios and Specifications
Table 103. NeuroPace Brain-computer Interface System Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 104. NeuroPace Main Business
Table 105. NeuroPace Latest Developments
Table 106. Emotiv Basic Information, Brain-computer Interface System Manufacturing Base, Sales Area and Its Competitors
Table 107. Emotiv Brain-computer Interface System Product Portfolios and Specifications
Table 108. Emotiv Brain-computer Interface System Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 109. Emotiv Main Business
Table 110. Emotiv Latest Developments
Table 111. NeuroSky Basic Information, Brain-computer Interface System Manufacturing Base, Sales Area and Its Competitors
Table 112. NeuroSky Brain-computer Interface System Product Portfolios and Specifications
Table 113. NeuroSky Brain-computer Interface System Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 114. NeuroSky Main Business
Table 115. NeuroSky Latest Developments
Table 116. ANT Neuro Basic Information, Brain-computer Interface System Manufacturing Base, Sales Area and Its Competitors
Table 117. ANT Neuro Brain-computer Interface System Product Portfolios and Specifications
Table 118. ANT Neuro Brain-computer Interface System Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 119. ANT Neuro Main Business
Table 120. ANT Neuro Latest Developments
Table 121. Blackrock Neurotech Basic Information, Brain-computer Interface System Manufacturing Base, Sales Area and Its Competitors
Table 122. Blackrock Neurotech Brain-computer Interface System Product Portfolios and Specifications
Table 123. Blackrock Neurotech Brain-computer Interface System Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 124. Blackrock Neurotech Main Business
Table 125. Blackrock Neurotech Latest Developments
Table 126. Synchron Basic Information, Brain-computer Interface System Manufacturing Base, Sales Area and Its Competitors
Table 127. Synchron Brain-computer Interface System Product Portfolios and Specifications
Table 128. Synchron Brain-computer Interface System Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 129. Synchron Main Business
Table 130. Synchron Latest Developments
Table 131. g.tec medical engineering GmbH Basic Information, Brain-computer Interface System Manufacturing Base, Sales Area and Its Competitors
Table 132. g.tec medical engineering GmbH Brain-computer Interface System Product Portfolios and Specifications
Table 133. g.tec medical engineering GmbH Brain-computer Interface System Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 134. g.tec medical engineering GmbH Main Business
Table 135. g.tec medical engineering GmbH Latest Developments
Table 136. Brain Products Basic Information, Brain-computer Interface System Manufacturing Base, Sales Area and Its Competitors
Table 137. Brain Products Brain-computer Interface System Product Portfolios and Specifications
Table 138. Brain Products Brain-computer Interface System Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 139. Brain Products Main Business
Table 140. Brain Products Latest Developments
Table 141. Bitbrain Basic Information, Brain-computer Interface System Manufacturing Base, Sales Area and Its Competitors
Table 142. Bitbrain Brain-computer Interface System Product Portfolios and Specifications
Table 143. Bitbrain Brain-computer Interface System Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 144. Bitbrain Main Business
Table 145. Bitbrain Latest Developments
Table 146. Precision Neuroscience Basic Information, Brain-computer Interface System Manufacturing Base, Sales Area and Its Competitors
Table 147. Precision Neuroscience Brain-computer Interface System Product Portfolios and Specifications
Table 148. Precision Neuroscience Brain-computer Interface System Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 149. Precision Neuroscience Main Business
Table 150. Precision Neuroscience Latest Developments
Table 151. Paradromics Basic Information, Brain-computer Interface System Manufacturing Base, Sales Area and Its Competitors
Table 152. Paradromics Brain-computer Interface System Product Portfolios and Specifications
Table 153. Paradromics Brain-computer Interface System Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 154. Paradromics Main Business
Table 155. Paradromics Latest Developments
Table 156. InteraXon Basic Information, Brain-computer Interface System Manufacturing Base, Sales Area and Its Competitors
Table 157. InteraXon Brain-computer Interface System Product Portfolios and Specifications
Table 158. InteraXon Brain-computer Interface System Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 159. InteraXon Main Business
Table 160. InteraXon Latest Developments
Table 161. Neurable Basic Information, Brain-computer Interface System Manufacturing Base, Sales Area and Its Competitors
Table 162. Neurable Brain-computer Interface System Product Portfolios and Specifications
Table 163. Neurable Brain-computer Interface System Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 164. Neurable Main Business
Table 165. Neurable Latest Developments
Table 166. Mentalab Basic Information, Brain-computer Interface System Manufacturing Base, Sales Area and Its Competitors
Table 167. Mentalab Brain-computer Interface System Product Portfolios and Specifications
Table 168. Mentalab Brain-computer Interface System Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 169. Mentalab Main Business
Table 170. Mentalab Latest Developments
Table 171. mBrainTrain Basic Information, Brain-computer Interface System Manufacturing Base, Sales Area and Its Competitors
Table 172. mBrainTrain Brain-computer Interface System Product Portfolios and Specifications
Table 173. mBrainTrain Brain-computer Interface System Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 174. mBrainTrain Main Business
Table 175. mBrainTrain Latest Developments
Table 176. Neuroelectrics Basic Information, Brain-computer Interface System Manufacturing Base, Sales Area and Its Competitors
Table 177. Neuroelectrics Brain-computer Interface System Product Portfolios and Specifications
Table 178. Neuroelectrics Brain-computer Interface System Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 179. Neuroelectrics Main Business
Table 180. Neuroelectrics Latest Developments
Table 181. CGX Systems (formerly Cognionics) Basic Information, Brain-computer Interface System Manufacturing Base, Sales Area and Its Competitors
Table 182. CGX Systems (formerly Cognionics) Brain-computer Interface System Product Portfolios and Specifications
Table 183. CGX Systems (formerly Cognionics) Brain-computer Interface System Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 184. CGX Systems (formerly Cognionics) Main Business
Table 185. CGX Systems (formerly Cognionics) Latest Developments
Table 186. Neurosity Basic Information, Brain-computer Interface System Manufacturing Base, Sales Area and Its Competitors
Table 187. Neurosity Brain-computer Interface System Product Portfolios and Specifications
Table 188. Neurosity Brain-computer Interface System Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 189. Neurosity Main Business
Table 190. Neurosity Latest Developments
Table 191. Wearable Sensing Basic Information, Brain-computer Interface System Manufacturing Base, Sales Area and Its Competitors
Table 192. Wearable Sensing Brain-computer Interface System Product Portfolios and Specifications
Table 193. Wearable Sensing Brain-computer Interface System Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 194. Wearable Sensing Main Business
Table 195. Wearable Sensing Latest Developments
Table 196. Compumedics Neuroscan Basic Information, Brain-computer Interface System Manufacturing Base, Sales Area and Its Competitors
Table 197. Compumedics Neuroscan Brain-computer Interface System Product Portfolios and Specifications
Table 198. Compumedics Neuroscan Brain-computer Interface System Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 199. Compumedics Neuroscan Main Business
Table 200. Compumedics Neuroscan Latest Developments
Table 201. SmartCap(Wenco) Basic Information, Brain-computer Interface System Manufacturing Base, Sales Area and Its Competitors
Table 202. SmartCap(Wenco) Brain-computer Interface System Product Portfolios and Specifications
Table 203. SmartCap(Wenco) Brain-computer Interface System Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 204. SmartCap(Wenco) Main Business
Table 205. SmartCap(Wenco) Latest Developments
Table 206. Shimadzu Basic Information, Brain-computer Interface System Manufacturing Base, Sales Area and Its Competitors
Table 207. Shimadzu Brain-computer Interface System Product Portfolios and Specifications
Table 208. Shimadzu Brain-computer Interface System Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 209. Shimadzu Main Business
Table 210. Shimadzu Latest Developments
Table 211. BrainCo Basic Information, Brain-computer Interface System Manufacturing Base, Sales Area and Its Competitors
Table 212. BrainCo Brain-computer Interface System Product Portfolios and Specifications
Table 213. BrainCo Brain-computer Interface System Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 214. BrainCo Main Business
Table 215. BrainCo Latest Developments
Table 216. Neuracle Technology Basic Information, Brain-computer Interface System Manufacturing Base, Sales Area and Its Competitors
Table 217. Neuracle Technology Brain-computer Interface System Product Portfolios and Specifications
Table 218. Neuracle Technology Brain-computer Interface System Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 219. Neuracle Technology Main Business
Table 220. Neuracle Technology Latest Developments
Table 221. CUSOFT Basic Information, Brain-computer Interface System Manufacturing Base, Sales Area and Its Competitors
Table 222. CUSOFT Brain-computer Interface System Product Portfolios and Specifications
Table 223. CUSOFT Brain-computer Interface System Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 224. CUSOFT Main Business
Table 225. CUSOFT Latest Developments
Table 226. Deayea Basic Information, Brain-computer Interface System Manufacturing Base, Sales Area and Its Competitors
Table 227. Deayea Brain-computer Interface System Product Portfolios and Specifications
Table 228. Deayea Brain-computer Interface System Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 229. Deayea Main Business
Table 230. Deayea Latest Developments
Table 231. Entertech Basic Information, Brain-computer Interface System Manufacturing Base, Sales Area and Its Competitors
Table 232. Entertech Brain-computer Interface System Product Portfolios and Specifications
Table 233. Entertech Brain-computer Interface System Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 234. Entertech Main Business
Table 235. Entertech Latest Developments
Table 236. HNNK Basic Information, Brain-computer Interface System Manufacturing Base, Sales Area and Its Competitors
Table 237. HNNK Brain-computer Interface System Product Portfolios and Specifications
Table 238. HNNK Brain-computer Interface System Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 239. HNNK Main Business
Table 240. HNNK Latest Developments
Table 241. StairMed Basic Information, Brain-computer Interface System Manufacturing Base, Sales Area and Its Competitors
Table 242. StairMed Brain-computer Interface System Product Portfolios and Specifications
Table 243. StairMed Brain-computer Interface System Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 244. StairMed Main Business
Table 245. StairMed Latest Developments
Table 246. NeuroXess Basic Information, Brain-computer Interface System Manufacturing Base, Sales Area and Its Competitors
Table 247. NeuroXess Brain-computer Interface System Product Portfolios and Specifications
Table 248. NeuroXess Brain-computer Interface System Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 249. NeuroXess Main Business
Table 250. NeuroXess Latest Developments
Table 251. Enlight Medical Basic Information, Brain-computer Interface System Manufacturing Base, Sales Area and Its Competitors
Table 252. Enlight Medical Brain-computer Interface System Product Portfolios and Specifications
Table 253. Enlight Medical Brain-computer Interface System Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 254. Enlight Medical Main Business
Table 255. Enlight Medical Latest Developments
Table 256. Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Basic Information, Brain-computer Interface System Manufacturing Base, Sales Area and Its Competitors
Table 257. Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Brain-computer Interface System Product Portfolios and Specifications
Table 258. Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Brain-computer Interface System Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 259. Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Main Business
Table 260. Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Latest Developments
Table 261. Hanix Basic Information, Brain-computer Interface System Manufacturing Base, Sales Area and Its Competitors
Table 262. Hanix Brain-computer Interface System Product Portfolios and Specifications
Table 263. Hanix Brain-computer Interface System Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 264. Hanix Main Business
Table 265. Hanix Latest Developments
Table 266. Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Basic Information, Brain-computer Interface System Manufacturing Base, Sales Area and Its Competitors
Table 267. Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Brain-computer Interface System Product Portfolios and Specifications
Table 268. Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Brain-computer Interface System Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 269. Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Main Business
Table 270. Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Latest Developments
Table 271. Beijing Xinzhida Neural Technology Co., Ltd Basic Information, Brain-computer Interface System Manufacturing Base, Sales Area and Its Competitors
Table 272. Beijing Xinzhida Neural Technology Co., Ltd Brain-computer Interface System Product Portfolios and Specifications
Table 273. Beijing Xinzhida Neural Technology Co., Ltd Brain-computer Interface System Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 274. Beijing Xinzhida Neural Technology Co., Ltd Main Business
Table 275. Beijing Xinzhida Neural Technology Co., Ltd Latest Developments
Table 276. Nanjing Vishee Medical Technology Co., Ltd. Basic Information, Brain-computer Interface System Manufacturing Base, Sales Area and Its Competitors
Table 277. Nanjing Vishee Medical Technology Co., Ltd. Brain-computer Interface System Product Portfolios and Specifications
Table 278. Nanjing Vishee Medical Technology Co., Ltd. Brain-computer Interface System Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 279. Nanjing Vishee Medical Technology Co., Ltd. Main Business
Table 280. Nanjing Vishee Medical Technology Co., Ltd. Latest Developments
Table 281. Xiangyu Medical Co.,Ltd. Basic Information, Brain-computer Interface System Manufacturing Base, Sales Area and Its Competitors
Table 282. Xiangyu Medical Co.,Ltd. Brain-computer Interface System Product Portfolios and Specifications
Table 283. Xiangyu Medical Co.,Ltd. Brain-computer Interface System Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 284. Xiangyu Medical Co.,Ltd. Main Business
Table 285. Xiangyu Medical Co.,Ltd. Latest Developments
Table 286. Jiangsu Apon Medical Technology Co.,Ltd. Basic Information, Brain-computer Interface System Manufacturing Base, Sales Area and Its Competitors
Table 287. Jiangsu Apon Medical Technology Co.,Ltd. Brain-computer Interface System Product Portfolios and Specifications
Table 288. Jiangsu Apon Medical Technology Co.,Ltd. Brain-computer Interface System Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 289. Jiangsu Apon Medical Technology Co.,Ltd. Main Business
Table 290. Jiangsu Apon Medical Technology Co.,Ltd. Latest Developments
Table 291. Boling Brain Machine (Hangzhou) Technology Co., Ltd. Basic Information, Brain-computer Interface System Manufacturing Base, Sales Area and Its Competitors
Table 292. Boling Brain Machine (Hangzhou) Technology Co., Ltd. Brain-computer Interface System Product Portfolios and Specifications
Table 293. Boling Brain Machine (Hangzhou) Technology Co., Ltd. Brain-computer Interface System Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 294. Boling Brain Machine (Hangzhou) Technology Co., Ltd. Main Business
Table 295. Boling Brain Machine (Hangzhou) Technology Co., Ltd. Latest Developments
Table 296. Medlander Basic Information, Brain-computer Interface System Manufacturing Base, Sales Area and Its Competitors
Table 297. Medlander Brain-computer Interface System Product Portfolios and Specifications
Table 298. Medlander Brain-computer Interface System Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 299. Medlander Main Business
Table 300. Medlander Latest Developments
Table 301. Shanghai HeartCare Medical Technology Corporation Limited Basic Information, Brain-computer Interface System Manufacturing Base, Sales Area and Its Competitors
Table 302. Shanghai HeartCare Medical Technology Corporation Limited Brain-computer Interface System Product Portfolios and Specifications
Table 303. Shanghai HeartCare Medical Technology Corporation Limited Brain-computer Interface System Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 304. Shanghai HeartCare Medical Technology Corporation Limited Main Business
Table 305. Shanghai HeartCare Medical Technology Corporation Limited Latest Developments
Table 306. Beijing Chieftain Control Engineering Technology Co., Ltd. Basic Information, Brain-computer Interface System Manufacturing Base, Sales Area and Its Competitors
Table 307. Beijing Chieftain Control Engineering Technology Co., Ltd. Brain-computer Interface System Product Portfolios and Specifications
Table 308. Beijing Chieftain Control Engineering Technology Co., Ltd. Brain-computer Interface System Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 309. Beijing Chieftain Control Engineering Technology Co., Ltd. Main Business
Table 310. Beijing Chieftain Control Engineering Technology Co., Ltd. Latest Developments
Table 311. Kingfar International,Inc. Basic Information, Brain-computer Interface System Manufacturing Base, Sales Area and Its Competitors
Table 312. Kingfar International,Inc. Brain-computer Interface System Product Portfolios and Specifications
Table 313. Kingfar International,Inc. Brain-computer Interface System Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 314. Kingfar International,Inc. Main Business
Table 315. Kingfar International,Inc. Latest Developments

List of Figures
Figure 1. Picture of Brain-computer Interface System
Figure 2. Brain-computer Interface System Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Brain-computer Interface System Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Brain-computer Interface System Revenue Growth Rate 2021-2032 ($ millions)